Nouri Neamati

发表

Discovery of Novel CXCR2 Inhibitors Using Ligand-Based Pharmacophore Models

Henry Ho, Bikash Debnath, Helen Ha, 2015, J. Chem. Inf. Model..

Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design

Kiran Boppana, Pavan Kumar Machiraju, Sarma A R P Jagarlapudi, 2019, Comput. Biol. Chem..

Structure-based inhibitor design targeting HIV-1 integrase.

Alexander D. MacKerell, Alexander D MacKerell, Nouri Neamati, 2002, Current drug targets. Infectious disorders.

Ricerca di nuovi inibitori selettivi dell'HIV-1 integrasi

Roberto Dallocchio, Paola Maria Manconi, Fabrizio Carta, 2004 .

A nanoscale graphene oxide-peptide biosensor for real-time specific biomarker detection on the cell surface.

Zhe Wang, Albert Jin, Nouri Neamati, 2012, Chemical communications.

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.

Divya Pathania, Nouri Neamati, N. Neamati, 2009, Advanced drug delivery reviews.

New Paradigms in Drug Design and Discovery

Joseph J. Barchi, Nouri Neamati, 2004 .

Discovery of Small Molecule Integrin αvβ3 Antagonists as Novel Anticancer Agents

Nouri Neamati, Jinxia Deng, Antonio Garofalo, 2006 .

Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.

Zeger Debyser, Nouri Neamati, Frauke Christ, 2013, Journal of medicinal chemistry.

De novo design and synthesis of HIV-1 integrase inhibitors.

Mahindra T. Makhija, Nouri Neamati, N. Neamati, 2004, Bioorganic & medicinal chemistry.

Design and Synthesis of Novel Dihydroxyindole-2-Carboxylic Acids as HIV-1 Integrase Inhibitors

Roberto Dallocchio, Alberto Mariani, Fabrizio Carta, 2004, Antiviral chemistry & chemotherapy.

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Asim Kumar Debnath, Shibo Jiang, Nouri Neamati, 2005, Virology.

From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes.

Elenia Duce, Laith Q Al-Mawsawi, Nouri Neamati, 2006, Journal of medicinal chemistry.

Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.

Ramadevi Sanam, Nouri Neamati, Ravikumar Muttineni, 2008, Journal of medicinal chemistry.

Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.

Nouri Neamati, Omoshile Clement, Tino Sanchez, 2005, Journal of medicinal chemistry.

Metal-dependent inhibition of HIV-1 integrase.

Dirk Strumberg, Marc C Nicklaus, Yves Pommier, 2002, Journal of medicinal chemistry.

HIV‐1 integrase inhibitors: 2007–2008 update

Srinivas Odde, Nouri Neamati, Erik Serrao, 2010, Medicinal research reviews.

Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga

Nouri Neamati, N. Neamati, 2002 .

Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.

Myriam Witvrouw, Zeger Debyser, Laith Q Al-Mawsawi, 2008, Journal of medicinal chemistry.

Small-molecule inhibitors of p53-MDM2 interaction: the 2006-2010 update.

Divya Pathania, Nouri Neamati, Shili Xu, 2011, Current pharmaceutical design.

New paradigms in drug design and discovery.

Nouri Neamati, N. Neamati, J. Barchi, 2002, Current topics in medicinal chemistry.

Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.

Yun Tang, Yves Pommier, Nouri Neamati, 2002, Journal of medicinal chemistry.

VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription.

Nouri Neamati, Kyu Heo, Woojin An, 2013, Molecular cell.

Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.

Nouri Neamati, Haregewein Assefa, Shantaram Kamath, 2004, Journal of medicinal chemistry.

HIV‐1 integrase inhibitors: 2005–2006 update

Nouri Neamati, R. Dayam, N. Neamati, 2008, Medicinal research reviews.

Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy.

Laith Q Al-Mawsawi, Nouri Neamati, N. Neamati, 2007, Trends in pharmacological sciences.

Small Molecule Inhibitors of CXCR4

Nouri Neamati, Shili Xu, Fedora Grande, 2013, Theranostics.

Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.

Nunzio Bottini, Sheng Li, Tong Liu, 2011, Journal of medicinal chemistry.

Design of second generation HIV-1 integrase inhibitors.

Laith Q Al-Mawsawi, Nouri Neamati, Jinxia Deng, 2007, Current pharmaceutical design.

Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.

Myriam Witvrouw, Christoph H Borchers, Laith Q Al-Mawsawi, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Inhibitory profile of a LEDGF/p75 peptide against HIV‐1 integrase: Insight into integrase–DNA complex formation and catalysis

Zeger Debyser, Nouri Neamati, Frauke Christ, 2008, FEBS letters.

HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding.

Nouri Neamati, Alessia Bacchi, Mauro Carcelli, 2011, Molecular pharmaceutics.

Allosteric Inhibitor Development Targeting HIV‐1 Integrase

Laith Q Al-Mawsawi, Nouri Neamati, N. Neamati, 2011, ChemMedChem.

Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.

Geeta Mehta, Nouri Neamati, Pooja Mehta, 2018, Journal of medicinal chemistry.